• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION COREVALVE 29MM AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION COREVALVE 29MM AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number MCS-P3-29-AOA-US
Device Problems Difficult To Position (1467); Premature Activation (1484); Unintended Movement (3026)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/06/2015
Event Type  Injury  
Event Description
Medtronic received information that during its positioning, this transcatheter bioprosthetic valve was deployed too high and moved from its targeted position.As the valve was being withdrawn, the tension created by the patient¿s ascending aortic arch against the delivery catheter system (dcs) opened the dcs capsule far enough for the valve¿s frame loops to release from the dcs tabs.The valve was deployed in the ascending aorta.A second valve was then successfully implanted.The physician reported that the malposition of the first valve was the result of the deployment attempt being initiated too high in the annulus.No adverse patient effects were reported.
 
Manufacturer Narrative
The valve remains implanted and therefore has not been returned to medtronic.There was no allegation against the dcs, which was discarded after the procedure.(b)(4).
 
Manufacturer Narrative
Conclusion: the reported clinical observation does not indicate a potential manufacturing issue.Potential factors that can influence a valve dislodgement include tension applied on the delivery catheter system (dcs) during positioning, calcification levels and compliance of the native anatomy, and a number of others.It should be noted that dislodgement complaints are typically not related to a device malfunction.This event does not allege a device malfunction occurred.In this case, during the implant of this transcatheter bioprosthetic valve, the valve was deployed too high and dislodged when at two-thirds deployment.Per the physician, deployment of the first valve had been initiated too high in the annulus.However, a conclusive root cause of the dislodgement could not be established from the information available.Per corevalve instructions for use (ifu), ¿once deployment is initiated, retrieval of the bioprosthesis from the patient (e.G., use of the catheter) is not recommended.Retrieval of a partially deployed valve using the catheter may cause mechanical failure of the delivery catheter system, aortic root damage, coronary artery damage, myocardial damage, vascular complications, prosthetic valve dysfunction (including device malposition), embolization, stroke, and/or emergent surgery.¿.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COREVALVE 29MM AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4468423
MDR Text Key17578211
Report Number2025587-2015-00103
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative,company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/07/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/09/2016
Device Model NumberMCS-P3-29-AOA-US
Device Catalogue NumberMCS-P3-29-AOA-US
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received08/07/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/22/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-